A Study to Evaluate the DDI of HSK7653 With Metformin

NCT06084156 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: HSK7653
DRUG: Metformin

Sponsor

Haisco Pharmaceutical Group Co., Ltd.